Evidence map›Paper›PMID 36354504›Full record

ArticleBiosensors2022

Rapid Bacteria Detection from Patients' Blood Bypassing Classical Bacterial Culturing.

François Huber, Hans Peter Lang, Stefanie Heller, Julia Anna Bielicki, Christoph Gerber, Ernst Meyer, Adrian Egli

Open access · goldAbstract read
In one paragraph

Article in Biosensors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Lab sciences: Going beyond the realms of diagnosis!!Medical journal, Armed Forces India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

François HuberSwiss Nanoscience Institute (SNI), Department of Physics, University of Basel, CH-4056 Basel, Switzerland.ORCID 0000-0003-4826-1245
Hans Peter LangSwiss Nanoscience Institute (SNI), Department of Physics, University of Basel, CH-4056 Basel, Switzerland.ORCID 0000-0002-0012-2564
Stefanie HellerApplied Microbiology Research (Lab 315), Zentrum für Lehre und Forschung, Department of Biomedicine, University of Basel, CH-4031 Basel, Switzerland.
Julia Anna BielickiUniversity Children's Hospital Basel (UKBB), Department of Medicine, University of Basel, CH-4056 Basel, Switzerland.
Christoph GerberSwiss Nanoscience Institute (SNI), Department of Physics, University of Basel, CH-4056 Basel, Switzerland.
Ernst MeyerSwiss Nanoscience Institute (SNI), Department of Physics, University of Basel, CH-4056 Basel, Switzerland.ORCID 0000-0001-6385-3412
Adrian EgliApplied Microbiology Research (Lab 315), Zentrum für Lehre und Forschung, Department of Biomedicine, University of Basel, CH-4031 Basel, Switzerland.
University of Basel · CH

Funding

European Research Council 834402Swiss National Science Foundation 180541Swiss National Science Foundation 407240_177354The Gottfried and Julia Bangerter-Rhyner-Foundation 0003/2021-0097/2022
6 · The paper itself

Abstract

Sepsis is a life-threatening condition mostly caused by a bacterial infection resulting in inflammatory reaction and organ dysfunction if not treated effectively. Rapid identification of the causing bacterial pathogen already in the early stage of bacteremia is therefore vital. Current technologies still rely on time-consuming procedures including bacterial culturing up to 72 h. Our approach is based on ultra-rapid and highly sensitive nanomechanical sensor arrays. In measurements we observe two clearly distinguishable distributions consisting of samples with bacteria and without bacteria respectively. Compressive surface stress indicates the presence of bacteria. For this proof-of-concept, we extracted total RNA from EDTA whole blood samples from patients with blood-culture-confirmed bacteremia, which is the reference standard in diagnostics. We determined the presence or absence of bacterial RNA in the sample through 16S-rRNA hybridization and species-specific probes using nanomechanical sensor arrays. Via both probes, we identified two clinically highly-relevant bacterial species i.e.,

Indexed as

BacteremiaSepsisBacteriaEdetic AcidEscherichia coliHumansRNA, Ribosomal, 16SEdetic AcidRNA, Ribosomal, 16Sbacteremiabacterial infectionsblood samplescantileversnanomechanical biosensorsrapid sensitive diagnosticssepsistotal RNA

Identifiers

PMID36354504
PMCPMC9688106
OpenAlexW4308868365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.